April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Prevention of Oxygen Induced Retinopathy by Systemic PHD Inhibition is Associated with Hepatic but not Retinal Erythropoietin Transcription
Author Affiliations & Notes
  • John Au
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • George Hoppe
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Maria J. Zutel
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Jonathan E. Sears
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  John Au, None; George Hoppe, None; Maria J. Zutel, None; Jonathan E. Sears, None
  • Footnotes
    Support  Research to Prevent Blindness Challenge Grant, Cleveland Clinic Product Development Fund, Knights Templar Eye Foundation.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3983. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John Au, George Hoppe, Maria J. Zutel, Jonathan E. Sears; Prevention of Oxygen Induced Retinopathy by Systemic PHD Inhibition is Associated with Hepatic but not Retinal Erythropoietin Transcription. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3983.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Hyperoxia is hypothesized to cause retinovascular growth attenuation and vascular obliteration by stimulating the catabolism of hypoxia inducible factor (HIF). Systemic blockade of HIF degradation through HIF prolyl hydroxylase inhibition (HIF PHDi) prevents oxygen-induced retinopathy (OIR). In order to understand whether this protective response is initiated in the liver or locally in the eye, we compared retinal and hepatic erythropoietin (Epo), PHD 1,2,3, and HIF-1a mRNA after systemic HIF PHDi.

Methods: : Dimethyloxalylglycine (DMOG) was injected intraperitoneally (200 µg/g) at P7 and mice exposed to hyperoxia for 12 hours. Control injections were comprised of intraperitoneal phosphate buffered solution (PBS). A standard mouse OIR model was also used to compare effects of hyperoxia and DMOG. Total RNA isolated from liver, kidney, brain, and retina was analyzed for the levels of Epo, PHD1,2,3, and HIF-1 mRNA using quantitative PCR.

Results: : By P12 in OIR model, hyperoxia drastically downregulated expression of Epo in all tested tissues (by 60 to 90%). Return to normoxia resulted in an expected 10-fold induction of retinal Epo mRNA, whereas hepatic Epo transcription remained significantly repressed (40% of control). In contrast, a single intraperitoneal injection of DMOG produced a 12-fold increase in Epo mRNA from liver yet barely discernable increases in Epo mRNA in kidney, brain, and retina at P8. The liver expresses more PHD 1 and 3 than retina. PHD 2 is the major retinal isoform. HIF-1a transcription in all tissues was unaffected by hyperoxia/normoxia treatment, but curiously, HIF-1a mRNA was increased by DMOG especially in the liver. While retinal HIF-1a mRNA only doubled, its hepatic levels rose 7 times after DMOG treatment.

Conclusions: : Hepatic Epo transcription fails to be activated by changes in oxygen but is exquisitely sensitive to systemic HIF PHDi. These findings reaffirm the concept that the liver could be efficiently induced to protect multiple end organs during hyperoxia. Transcriptional upregulation of HIF-1α by DMOG may suggest a retinal rescue pathway that is independent of the canonical HIF posttranslational stabilization.

Keywords: retinopathy of prematurity • hypoxia • vascular occlusion/vascular occlusive disease 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.